Default company panoramic image
D77880bd 9576 4d51 a803 797ec80b7e4f

Gene Predictis SA

We are a Swiss company dedicated to personalized medicine. We produce and commercialize innovative, clinically relevant, diagnostic tools based on genetics.

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Lausanne, Switzerland
  • Currency CHF
  • Employees 9
  • Website

Company Summary

We are a Swiss company dedicated to personalized medicine. We produce and commercialize innovative diagnostic tools based on genetics. Our products enable to improve drug treatment efficacy and reduce harmful side effects resulting from adverse drug reactions. These benefits will considerably reduce the cost of drug-related morbidity and mortality, estimated in the US alone at 177 billion US$. Our clients are health-care professionals.


  • Default avatar
    Goranka Tanackovic Abbas-Terki

    After successful career in research, Dr Tanackovic joined Gene Predictis in 2011. In these two years, she changed the vision and the strategy of the company with the buy-in of the board and the team. The team grew from 5 to 9 employees; she recruited and built highly performing team committed to the new vision and strategy. Development of the new and improvements of the existing products, allowed her to reposition the company on the market.

  • Default avatar
    Joëlle Michaud

    Dr Michaud joined Gene Predictis in July 2011, following a successful time as a researcher in medical genetics and genomics. In the past two years, she has developed Gene Predictis' catalogue with number of new tests notably related to pharmacogenetics, oncology and nutrigenetics along with clear and high quality reports. She has also implemented specific algorithms estimating risk factors for frequent diseases.


  • Default avatar
    Maitre Frédéric Rochat
    Default avatar
    Stéphane Cretex